Latest news
The Top 5 Analyst Questions From Regeneron’s Q2 Earnings Call - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 05:45:00 GMTRegeneron Pharma Q2 Earnings: EYLEA HD Outsold EYLEA for the First Time - TIKR.comTIKR.com · Mon, 03 Aug 2026 10:24:38 GMTRegeneron Earnings Call Highlights Dupixent-Driven Surge - The Globe and MailThe Globe and Mail · Fri, 31 Jul 2026 07:00:00 GMTRegeneron Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 30 Jul 2026 19:04:31 GMTREGN: Q2 2026 revenue up 17% with record Dupixent, EYLEA HD, and Libtayo sales; EPS up 11% - TradingViewTradingView · Thu, 30 Jul 2026 11:18:28 GMTRegeneron Q2 Earnings Beat, Sales Up on Dupixent & Eylea HD Strength - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMTRegeneron Q2 revenue beats on higher Dupixent, Eylea HD sales - BitgetBitget · Thu, 30 Jul 2026 07:00:00 GMTREGN Q2 Deep Dive: Pipeline Progress and Product Momentum Drive Outperformance - StockStoryStockStory · Thu, 30 Jul 2026 07:00:00 GMT